Acccording to G.S.Burrill,CEO of Burrill & Co. of San Francisco,the biotech industry raised $16.3B in 2003 which was the second best year in biotech's financing history.<g>
The FDA approved more than 19 biotech drugs in 2003 and with the passage of the $400B Medicare Prescription Drug on December 8, "biotech has a new Medicare partner," he also said that under the leadership of Commissioner Mark McClellan there is already some acceleration of the drug approval process.
Among Biotech movers he mentioned are NGEN,CRGN, MLNM, XOMA,PDLI,TKTX,AMGN,ELN,CERS,ZGEN,ESPR,NRGN,VLGC and CPHD
nachrichten.boerse.de
Bernard |
